Y Caraco, GE Crofoot, PA Moncada… - NEJM …, 2022 - evidence.nejm.org
… dose-limiting in this small sample of nonhospitalizedadults with Covid-19. The … molnupiravir, when initiated early in the course of illness, is an effective option for the treatment of adults …
… non-hospitalizedadults and assessed treatment initiation with nirmatrelvir/ritonavir or molnupiravir versus no antiviral treat… and/or molnupiravir were the intervention with the treatment …
PY Huang, TH Liu, JY Wu, YW Tsai… - Journal of Medical …, 2023 - Wiley Online Library
… These findings support the recommended use of molnupiravir for treatingnonhospitalized … and November 2021 Nonhospitalizedadults with COVID-19 within 5 days of symptom onset …
DV Parums - … science monitor: international medical journal of …, 2022 - ncbi.nlm.nih.gov
… significantly reduced the risk of hospitalization or death in adults … of molnupiravir given within five days after the onset of signs or symptoms in unvaccinated and non-hospitalizedadults …
RT Gandhi, PN Malani, C Del Rio - Jama, 2022 - jamanetwork.com
… theoretical concerns that molnupiravir may cause mutations in … Authorization for molnupiravir for treatment of adults with mild … Molnupiravir is not recommended during pregnancy and is …
S Bellino - Annals of medicine, 2022 - Taylor & Francis
… early use of molnupiravir (Lagevrio) before marketing authorization, under Article 5(3) of Regulation 726/2004. Molnupiravir can be used for the treatment of COVID-19 in adults who do …
… including molnupiravir and nirmatrelvir plus ritonavir are novel options for treatingadults … with COVID-19 received molnupiravir or nirmatrelvir plus ritonavir treatment in the outpatient …
CC Lai, YH Wang, KH Chen, CH Chen, CY Wang - Viruses, 2022 - mdpi.com
… The rank probability for each treatment calculated using the P… anti-viral treatment, followed by remdesivir and then molnupiravir. … and utilized to treatnon-hospitalizedadults with mild to …
SK Tippabhotla, DS Lahiri, C Kandi - 2022 - papers.ssrn.com
… , is being repurposed for the treatment of COVID-19. This study evaluates the efficacy and … of molnupiravir in addition to the standard-of-care (SOC) for the treatment of non-hospitalized …